Ignite Creation Date:
2024-05-06 @ 3:10 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04540848
Status:
WITHDRAWN
Last Update Posted:
2021-10-29
First Post:
2020-08-31
Brief Title:
Post Operative Pain Control for Distal Radius Surgery Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
Post Operative Pain Control for Distal Radius Surgery Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours
Status:
WITHDRAWN
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of ability to communicate with the study population
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see if Exparel used intraoperatively by injecting at the surgical site followed by a Supraclavicular nerve block with bupivacaine in the recovery room will provide better pain scores for patients at 24 and 48 hours post operatively than 1Bupivacaine Hydrochloride HCL injection at the surgical site with a supraclavicular block in Post-anesthesia care unitPACU or 2a supraclavicular block in PACU without any kind of injection at the surgical site
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None